Insider · CIK 0001376960

Aryeh Jason

CIK 0001376960 Name as filed on the most recent filing

Filed as Aryeh Jason (95)

204 transaction lines · from 95 filings · filed 2007-06-01 to 2026-06-12 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

204 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-27 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2010-03-17 S, Open-market sale Nabi BiopharmaceuticalsNABI 2 lines 67,881, disposed Open Form 4 filing 0001455244-10-000075
2010-03-15 S, Open-market sale Nabi BiopharmaceuticalsNABI 1,186, disposed Open Form 4 filing 0001455244-10-000066
2010-03-12 S, Open-market sale Nabi BiopharmaceuticalsNABI 2 lines 98,374, disposed Open Form 4 filing 0001455244-10-000063
2010-03-11 S, Open-market sale Nabi BiopharmaceuticalsNABI 1,062,335, disposed Open Form 4 filing 0001455244-10-000053
2010-03-10 S, Open-market sale Nabi BiopharmaceuticalsNABI 92,414, disposed Open Form 4 filing 0001455244-10-000040
2010-03-08 S, Open-market sale Nabi BiopharmaceuticalsNABI 18,393, disposed Open Form 4 filing 0001455244-10-000036
2010-01-13 S, Open-market sale Nabi BiopharmaceuticalsNABI 75,774, disposed Open Form 4 filing 0001455244-10-000032
2010-01-12 S, Open-market sale Nabi BiopharmaceuticalsNABI 473,367, disposed Open Form 4 filing 0001455244-10-000030
2010-01-08 S, Open-market sale Nabi BiopharmaceuticalsNABI 244,171, disposed Open Form 4 filing 0001455244-10-000013
2010-01-07 S, Open-market sale Nabi BiopharmaceuticalsNABI 18,213, disposed Open Form 4 filing 0001455244-10-000013
2010-01-06 S, Open-market sale Nabi BiopharmaceuticalsNABI 222,154, disposed Open Form 4 filing 0001455244-10-000013
2009-12-22 S, Open-market sale Nabi BiopharmaceuticalsNABI 42,103, disposed Open Form 4 filing 0001435420-09-000023
2009-12-16 S, Open-market sale Nabi BiopharmaceuticalsNABI 21,196, disposed Open Form 4 filing 0001455244-09-000135
2009-11-17 S, Open-market sale Nabi BiopharmaceuticalsNABI 21 lines 941,934, disposed Open Form 4 filing 0001455244-09-000126
2009-11-16 S, Open-market sale Nabi BiopharmaceuticalsNABI 463,104, disposed Open Form 4 filing 0001455244-09-000116
2009-11-16 S, Open-market sale Nabi BiopharmaceuticalsNABI 314,960, disposed Open Form 4 filing 0001455244-09-000116
2009-11-16 S, Open-market sale Nabi BiopharmaceuticalsNABI 172,819, disposed Open Form 4 filing 0001455244-09-000116
2009-11-16 S, Open-market sale Nabi BiopharmaceuticalsNABI 52,785, disposed Open Form 4 filing 0001455244-09-000116
2009-11-16 S, Open-market sale Nabi BiopharmaceuticalsNABI 41,471, disposed Open Form 4 filing 0001455244-09-000116
2009-11-16 S, Open-market sale Nabi BiopharmaceuticalsNABI 19,656, disposed Open Form 4 filing 0001455244-09-000116
2009-11-16 S, Open-market sale Nabi BiopharmaceuticalsNABI 15,525, disposed Open Form 4 filing 0001455244-09-000116
2009-11-16 S, Open-market sale Nabi BiopharmaceuticalsNABI 13,238, disposed Open Form 4 filing 0001455244-09-000116
2009-11-16 S, Open-market sale Nabi BiopharmaceuticalsNABI 12,312, disposed Open Form 4 filing 0001455244-09-000116
2009-11-16 S, Open-market sale Nabi BiopharmaceuticalsNABI 11,525, disposed Open Form 4 filing 0001455244-09-000116
2009-11-16 S, Open-market sale Nabi BiopharmaceuticalsNABI 11,475, disposed Open Form 4 filing 0001455244-09-000116
2009-11-16 S, Open-market sale Nabi BiopharmaceuticalsNABI 7,769, disposed Open Form 4 filing 0001455244-09-000116
2009-11-16 S, Open-market sale Nabi BiopharmaceuticalsNABI 6,006, disposed Open Form 4 filing 0001455244-09-000116
2009-11-16 S, Open-market sale Nabi BiopharmaceuticalsNABI 5,460, disposed Open Form 4 filing 0001455244-09-000116

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 88
  • Open-market sale 116
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Aryeh Jason, insider transactions. Retrieved 2026-08-27 from https://ebomi.com/insider/0001376960

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.